BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23350889)

  • 1. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA.
    Aschebrook-Kilfoy B; Caces DB; Ollberding NJ; Smith SM; Chiu BC
    Leuk Lymphoma; 2013 Aug; 54(8):1677-83. PubMed ID: 23350889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.
    Zhou Y; Wang H; Fang W; Romaguer JE; Zhang Y; Delasalle KB; Kwak L; Yi Q; Du XL; Wang M
    Cancer; 2008 Aug; 113(4):791-8. PubMed ID: 18615506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in mantle cell lymphoma in the United States.
    Wang Y; Ma S
    BMC Cancer; 2014 Oct; 14():764. PubMed ID: 25315847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival.
    Breen CT; Chao J; Mehra S; Kohli N
    Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):412-419. PubMed ID: 34137303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
    Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e312-e320. PubMed ID: 31029647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
    Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.
    Odejide OO; Cronin AM; Earle CC; LaCasce AS; Abel GA
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26438575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK; Khanal A
    Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas.
    Fu S; Wang M; Lairson DR; Li R; Zhao B; Du XL
    Oncotarget; 2017 Dec; 8(68):112516-112529. PubMed ID: 29348844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
    Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and Ethnic Disparities in the Incidence of Pediatric Extracranial Embryonal Tumors.
    Friedrich P; Itriago E; Rodriguez-Galindo C; Ribeiro K
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
    Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
    Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.
    Smedby KE; Hjalgrim H
    Semin Cancer Biol; 2011 Nov; 21(5):293-8. PubMed ID: 21945518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
    Cohen JB; Han X; Jemal A; Ward EM; Flowers CR
    Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program.
    Wong JR; Tucker MA; Kleinerman RA; Devesa SS
    JAMA Ophthalmol; 2014 Apr; 132(4):478-83. PubMed ID: 24577366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007.
    Chandran R; Gardiner SK; Simon M; Spurgeon SE
    Leuk Lymphoma; 2012 Aug; 53(8):1488-93. PubMed ID: 22242824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma epidemiology: a population-based study in France.
    Leux C; MaynadiƩ M; Troussard X; Cabrera Q; Herry A; Le Guyader-Peyrou S; Le Gouill S; Monnereau A
    Ann Hematol; 2014 Aug; 93(8):1327-33. PubMed ID: 24763513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
    Criscione VD; Weinstock MA
    Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.